JUBLPHARMANSEJubilant Pharmova LimitedMinimalNeutral
Announced Mon, 13 Apr · 18:11 IST

Hari Shanker Bharti Family Trust has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

JUBLPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.2%1-day move
₹890.00
prior close
₹907.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.4-0.1-0.3+0.1+2.2+2.8+1.4+2.2+4.5+7.1+10.4+10.7+11.3+13.4
Up moveDown movePending
AI summary

Hari Shanker Bhartia Family Trust has submitted an annual declaration confirming that promoters and persons acting in concert (PAC) of Jubilant Pharmova Limited have NOT created any new encumbrances on company shares during FY2026. The filing lists 21 entities/individuals in the promoter group, including the Bhartia family members and various family trusts and investment vehicles. The declaration covers the financial year ending March 31, 2026, and notes any encumbrances would be those already disclosed to the stock exchanges.

Likely market impact

This is a routine compliance filing and generally neutral for shareholders. The absence of new share encumbrances indicates promoters have not pledged shares as collateral, which reduces risk of potential share supply pressure in the market.